ABVC Biopharma Inc (ABVC) — Cash Flow Reinvestment Rate

Latest as of September 2024: 2.92x

ABVC Biopharma Inc (ABVC) has a Cash Flow Reinvestment Rate of 2.92x as of September 2024, reinvesting $501.62K (capex $3.00 plus investments $501.61K) from operating cash flow of $171.72K. Check how high is ABVC Biopharma Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

2.92x
(Capex + Investments) / Operating CF

Total Reinvested

$501.62K
Capex + Investments

Operating Cash Flow

$171.72K
USD

Capital Expenditures

$3.00
USD

ABVC Biopharma Inc Cash Flow Reinvestment Rate (2003–2015)

Historical reinvestment intensity for ABVC Biopharma Inc across 4 annual periods. Explore ABVC long-term investments to assets to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for ABVC Biopharma Inc (2003–2015)

Year-by-year capital reinvestment analysis for ABVC Biopharma Inc. For live market cap and broader valuation context, see ABVC stock market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.00x $0.00 $3.36K $0.00 ▼ -100.0%
2014 16.73x $19.55K $1.17K $19.55K
2006 0.00x $0.00 $24.45K $0.00
2003 0.00x $0.00 $355.00 $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow